×
Entrez Id:
6794
Gene Symbol:
STK11
STK11
0.410
GeneticVariation
disease
CLINVAR
×
Entrez Id:
6794
Gene Symbol:
STK11
STK11
0.410
GenomicAlterations
disease
CGI
×
Entrez Id:
6794
Gene Symbol:
STK11
STK11
0.410
CausalMutation
disease
CGI
×
Entrez Id:
6794
Gene Symbol:
STK11
STK11
0.410
CausalMutation
disease
CLINVAR
×
Entrez Id:
3815
Gene Symbol:
KIT
KIT
0.120
CausalMutation
disease
CLINVAR
×
Entrez Id:
8915
Gene Symbol:
BCL10
BCL10
0.100
CausalMutation
disease
CLINVAR
×
Entrez Id:
2261
Gene Symbol:
FGFR3
FGFR3
0.100
CausalMutation
disease
CLINVAR
×
Entrez Id:
1485
Gene Symbol:
CTAG1B
CTAG1B
0.100
Biomarker
disease
BEFREE
Cancer testis antigens (CTAs) are T-cell-defined tumor-associated antigens encoded by the genes and gene families such as MAGE, NY-ESO-1 , and others.
15515159
2004
×
Entrez Id:
246100
Gene Symbol:
CTAG1A
CTAG1A
0.100
Biomarker
disease
BEFREE
Cancer testis antigens (CTAs) are T-cell-defined tumor-associated antigens encoded by the genes and gene families such as MAGE, NY-ESO-1 , and others.
15515159
2004
×
Entrez Id:
54742
Gene Symbol:
LY6K
LY6K
0.010
Biomarker
disease
BEFREE
Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas.
18089789
2007
×
Entrez Id:
9043
Gene Symbol:
SPAG9
SPAG9
0.040
Biomarker
disease
BEFREE
Cancer testis antigen SPAG9 is a promising marker for the diagnosis and treatment of lung cancer.
26934841
2016
×
Entrez Id:
84692
Gene Symbol:
CCDC54
CCDC54
0.050
Biomarker
disease
BEFREE
Cancer testis antigen Sperm Protein 17 as a new target for triple negative breast cancer immunotherapy.
29088794
2017
×
Entrez Id:
53340
Gene Symbol:
SPA17
SPA17
0.050
Biomarker
disease
BEFREE
Cancer testis antigen Sperm Protein 17 as a new target for triple negative breast cancer immunotherapy.
29088794
2017
×
Entrez Id:
10761
Gene Symbol:
PLAC1
PLAC1
0.020
Biomarker
disease
BEFREE
Cancer/testis antigen-Plac1 promotes invasion and metastasis of breast cancer through Furin/NICD/PTEN signaling pathway.
29704427
2018
×
Entrez Id:
53340
Gene Symbol:
SPA17
SPA17
0.050
Biomarker
disease
BEFREE
Sp17 is therefore a novel member of the CT antigen family and should be an ideal target for immunotherapy of multiple myeloma.
11222401
2001
×
Entrez Id:
84692
Gene Symbol:
CCDC54
CCDC54
0.050
Biomarker
disease
BEFREE
Sp17 is therefore a novel member of the CT antigen family and should be an ideal target for immunotherapy of multiple myeloma.
11222401
2001
×
Entrez Id:
8900
Gene Symbol:
CCNA1
CCNA1
0.010
AlteredExpression
disease
BEFREE
Cyclin A1 is a tissue-specific cyclin that is highly expressed in acute myeloid leukemia and in testicular cancer .
14510182
2003
×
Entrez Id:
6406
Gene Symbol:
SEMG1
SEMG1
0.020
Biomarker
disease
BEFREE
Semenogelin 1 was also frequently coexpressed with other CT antigens, Sperm protein 17 and SPAN-Xb.
14595213
2004
×
Entrez Id:
7503
Gene Symbol:
XIST
XIST
0.020
Biomarker
disease
BEFREE
XIST unmethylated DNA fragments in male-derived plasma as a tumour marker for testicular cancer .
14723995
2004
×
Entrez Id:
246100
Gene Symbol:
CTAG1A
CTAG1A
0.100
Biomarker
disease
BEFREE
NY-ESO-1 is one of the most immunogenic cancer/testis (CT ) antigens and emerges as the potential candidate for specific immunotherapy.
15069548
2004
×
Entrez Id:
1485
Gene Symbol:
CTAG1B
CTAG1B
0.100
Biomarker
disease
BEFREE
NY-ESO-1 is one of the most immunogenic cancer/testis (CT ) antigens and emerges as the potential candidate for specific immunotherapy.
15069548
2004
×
Entrez Id:
51270
Gene Symbol:
TFDP3
TFDP3
0.010
Biomarker
disease
BEFREE
HCA661 is a novel cancer/testis (CT ) antigen screened by SEREX from sera of an HCC patient.
15083197
2004
×
Entrez Id:
472
Gene Symbol:
ATM
ATM
0.010
Biomarker
disease
BEFREE
ATM activation in normal human tissues and testicular cancer .
15846060
2005
×
Entrez Id:
10566
Gene Symbol:
AKAP3
AKAP3
0.030
Biomarker
disease
BEFREE
A-kinase anchoring protein 3 (AKAP-3 ) is a novel member of the CT antigen family.
16005946
2005
×
Entrez Id:
56915
Gene Symbol:
EXOSC5
EXOSC5
0.010
Biomarker
disease
BEFREE
CML28 , a recently discovered cancer-testis (CT ) antigen from chronic myelogenous leukemia, is considered to be a promising target of tumor-specific immunotherapy.
16534571
2006